| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/22/2008 | CA2225807C Use of lamellarin-class alkaloids in methods of treatment |
| 04/22/2008 | CA2174737C Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
| 04/22/2008 | CA2112395C Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 04/17/2008 | WO2008046107A2 Novel inhibitors of the egfr kinase targeting the asymmetric activating dimer interface |
| 04/17/2008 | WO2008045970A2 Compositions and methods of using chondroitinase abci mutants |
| 04/17/2008 | WO2008045905A1 Pyrrolydine derivatives as iap inhibitors |
| 04/17/2008 | WO2008045766A2 Method for treating skin |
| 04/17/2008 | WO2008045696A2 Methods and compositions for the treatment of vaginal diseases employing peroxide-producing enzymes and peroxidases |
| 04/17/2008 | WO2008045345A2 Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating nf-kappab or suppressing nf-kappab-mediated actions |
| 04/17/2008 | WO2008045330A2 Effective delivery of cross-species a3 adenosine-receptor antagonists to reduce intraocular pressure |
| 04/17/2008 | WO2008045238A2 Stabilized therapeutic small helical antiviral peptides |
| 04/17/2008 | WO2008045017A2 Sars and ebola inhibitors and use thereof, and methods for their discovery |
| 04/17/2008 | WO2008044928A1 Complement inhibition for improved nerve regeneration |
| 04/17/2008 | WO2008044852A1 Stable liquid compositions for treating stomatitis comprising epidermal growth factor |
| 04/17/2008 | WO2008044846A1 Peptides having activities of epidermal growth factor and its uses |
| 04/17/2008 | WO2008044798A1 Agent for introducing protein into cell |
| 04/17/2008 | WO2008044777A1 2-pyridinecarboxamide derivative having gk-activating activity |
| 04/17/2008 | WO2008044631A1 Therapeutic and/or ameliorating agent for disseminated intravascular coagulation |
| 04/17/2008 | WO2008044599A1 Polypeptide having activity of targeting intestine having inflammation, and use thereof |
| 04/17/2008 | WO2008044567A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
| 04/17/2008 | WO2008044562A1 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 04/17/2008 | WO2008044465A1 Method of utilizing thrombin as adjuvant |
| 04/17/2008 | WO2008044109A1 Reconstituted surfactants having improved properties |
| 04/17/2008 | WO2008043821A1 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and use thereof |
| 04/17/2008 | WO2008043797A1 Use of modified cyclosporins |
| 04/17/2008 | WO2008043767A1 Antimetastatic effect on human cell disorders |
| 04/17/2008 | WO2008043570A1 Interferon type i supporting compounds |
| 04/17/2008 | WO2008043424A2 Composition to treat or prevent gastrointestinal infection |
| 04/17/2008 | WO2008043241A1 A fusion protein carrying neurotrophin across the blood-brain barrier, encoding gene and uese thereof |
| 04/17/2008 | WO2008043175A1 SOLUBLE β-N-ACETYLGLUCOSAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
| 04/17/2008 | WO2008025856A3 Modified glycoproteins |
| 04/17/2008 | WO2008025516A3 Tnf superfamily fusion proteins |
| 04/17/2008 | WO2008025507A3 Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
| 04/17/2008 | WO2008024299A3 Combination with bis(thiohydrazide amides) for treating cancer |
| 04/17/2008 | WO2008022645A3 Ncam fibronectin type 3 binding peptides |
| 04/17/2008 | WO2008021536A3 Use of interferon tau for the manufacture of a medicament in combination with interferon-alpha or interferon-beta for reduction of their adverse effects |
| 04/17/2008 | WO2008019395A9 Compounds for improving learning and memory |
| 04/17/2008 | WO2008019187A3 Detecting and treating dementia |
| 04/17/2008 | WO2008015339A3 Recombinant factor vii composition |
| 04/17/2008 | WO2008003748A3 Cd300lg polypeptides and their use in treating autoimmune diseases |
| 04/17/2008 | WO2007144493A3 Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative |
| 04/17/2008 | WO2007141667A3 Immunosuppressive extract of cordyceps sinensis and uses thereof |
| 04/17/2008 | WO2007138538A3 Probiotic strain and antimicrobial peptide derived therefrom |
| 04/17/2008 | WO2007134326A3 Methods for treating autoimmune diseases using a taci-ig fusion molecule |
| 04/17/2008 | WO2007133749A3 Methods and compositions for treating and preventing peripheral nerve damage |
| 04/17/2008 | WO2007127951A3 Compositions and methods involving mda-7 for the treatment of cancer |
| 04/17/2008 | WO2007117440A3 Stimulation of neuron regeneration by secretory leukocyte protease inhibitor |
| 04/17/2008 | WO2006133144A8 Erythropoietin receptor peptide formulations and uses |
| 04/17/2008 | WO2006125963A3 Modified leukocyte ig-like receptor family members (lir' s) with increased affinity for class i mhc and their uses in modulating t cell activation |
| 04/17/2008 | WO1999001471A9 Nik proteins, nucleic acids and methods |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090904 S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090843 Pharmaceutical formulation for treatment of HBV infection comprising a compound that inhibits the activity of a Src kinase in an amount effective to inhibit HBV replication and a pharmaceutically acceptable carrier |
| 04/17/2008 | US20080090795 Pharmaceutical Compositions Based on Nk2 Antagonists for Pediatric Use |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/17/2008 | US20080090771 Modification of pharmacokinetic and pharmacological properties of hydrocodone through covalent modification by conjugating hydrocodone with a carrier selected from an amino acid, a dipeptide, a tripeptide, a tetrapeptide and a pentapeptide; analgesic; bioavailability |
| 04/17/2008 | US20080090770 Modulation of Muc1 Mediated Signal Transduction |
| 04/17/2008 | US20080090769 topical cream containing sulfadiazine combined with 5 mu g of epidermal growth factor shows improvement |
| 04/17/2008 | US20080090768 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 04/17/2008 | US20080090767 Agent for prophylaxis of reflex sympathetic dystrophy after cerebral apoplexy |
| 04/17/2008 | US20080090766 Preventive or therapeutic agents for diseases including interleukin-18 inhibitor as an active ingredient |
| 04/17/2008 | US20080090765 Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage |
| 04/17/2008 | US20080090764 Partially dePEGylated lysine/N-terminal positional PEG isomers of a recombinant G-CSF polypeptide, such recombinant G-CSF polypeptide containing the substitutions K16R, K34R, K40R, T105K and S159K relative to wild-type human G-CSF; increasing the level of neutrophils in a patient |
| 04/17/2008 | US20080090763 Novel gene encoding a dna repair enzyme and methods of use thereof |
| 04/17/2008 | US20080090762 Epithelum-derived T-cell factor |
| 04/17/2008 | US20080090761 Method Comprising Nanofiltration to Obtain an Mbl Product Safe from Infectious Agents and the Product Obtainable by This Method |
| 04/17/2008 | US20080090760 One or more individual peptide chains covalently linked to form dimers, homodimers heterodimers or multimers, optionally linked to linkers such as iminodiacetic acid, amino triacetate, goalpost 3, lysine amide, or modified by PEG; use for inhibiting angiogenesis and angiogenesis-related disease |
| 04/17/2008 | US20080090759 Methods and kits for predicting risk for preterm labor |
| 04/17/2008 | US20080090758 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| 04/17/2008 | US20080090757 Particularly Kahalalide F, a tridecapeptide with a ring shape side and a lateral side amidated with 5-methylhexanoic acid; 650 mu g/m2/day administered intravenously in cycles of 1-4 weeks; photosensitizing agent selected from methoxsalen, methotrexate, etretinate,corticosteroid, cyclosporine; nontoxic |
| 04/17/2008 | US20080090756 Somatostatin agonists |
| 04/17/2008 | US20080090755 Follistatin Variant Polypeptide |
| 04/17/2008 | US20080090754 A protein, e.g., insulin or a growth hormone; a polyol, e.g., mannitol or polyethylene glycol; zinc; stabilized against denaturing when in contact with an organic solvent |
| 04/17/2008 | US20080090753 Rapid Acting Injectable Insulin Compositions |
| 04/17/2008 | US20080090752 Anti-tumor vasculature effects of human serum albumin derivatives |
| 04/17/2008 | US20080090751 Method of promoting healing of a tympanic membrane perforation |
| 04/17/2008 | US20080090750 N-terminal sequences of human growth hormone, human placental lactogen, human growth hormone variant hGH-V, and prolactin; used in inhibiting angiogenesis, antiproliferative, and in the diagnosis of diseases of human pregnancy involving abnormal placenta, preeclampsia and intrauterine growth retardation |
| 04/17/2008 | US20080090749 Prophylactic/therapeutic agent for stress-induced bowel disease |
| 04/17/2008 | US20080090290 Nucleic Acids Encoding Anti-IL-12 Antibodies, and Methods of Production |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080089954 Diagnosis and treatment of human dormancy syndrome |
| 04/17/2008 | US20080089950 Lymphoid tissue inducers and an immunomodulatory agent; proliferative disorders, infectious diseases, cardiovascular diseases, inflammatory disorders and autoimmune disorders |
| 04/17/2008 | US20080089938 Compositions and methods for polynucleotide delivery |
| 04/17/2008 | US20080089930 Keratin-Based Powders and Hydrogel for Pharmaceutical Applications |
| 04/17/2008 | US20080089929 Immunogenic fusion comprising transcription and negative factor domains for use in generation vaccine for prevention and treatment of viral infections; immunostimulants |
| 04/17/2008 | US20080089923 Biodegradable ocular implants and methods for treating ocular conditions |
| 04/17/2008 | US20080089911 Borrelia burgdorferi outer surface protein ( OSP)C antigen and a second antigenic lipoprotein such as genetic engineered OSPA, or streptococcus pneumoniae cell surface protein ( PSPA) or both in same physio-chemical |
| 04/17/2008 | US20080089901 Hivcon: an hiv immunogen and uses thereof |
| 04/17/2008 | US20080089900 Identification of self and non-self antigens implicated in autoimmune disease |
| 04/17/2008 | US20080089897 ActRIIB Fusion Polypeptides and Uses Therefor |
| 04/17/2008 | US20080089896 Bivalent SMAC mimetics and the uses thereof |
| 04/17/2008 | US20080089895 Using antisense agents specific to lymphocyte membrane protein (TIRC7) as therapeutic tools in treatment and prevention of cell proliferative, vision and ischemic heart defects; wound healing agents |
| 04/17/2008 | US20080089893 therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies; Anticancer agent |
| 04/17/2008 | US20080089890 Methods of polypeptide production |
| 04/17/2008 | US20080089889 Novel Bone Metastasis Marker Peptide and Method of Diagnosing Bone Metastasis by Using the Same |
| 04/17/2008 | US20080089887 Members of the FC Receptor Homolog Gene Family (FcRH1-3,6) Related Reagents and Uses Thereof |
| 04/17/2008 | US20080089886 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/17/2008 | US20080089884 For treating and/or preventing bladder disorders; for decreasing the expression, release or biological activity of macrophage migration inhibition factor |
| 04/17/2008 | US20080089883 Antisense oligonucleotides for prevention and/or treatment of infection, asthma, skin, inflammatory and/or autoimmune disorders |